Loading…

Intravenous HYDROmorphone: Can You Manage the Risk?

In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of emergency nursing 2011-07, Vol.37 (4), p.377-380
Main Author: Paparella, Susan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473
cites cdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473
container_end_page 380
container_issue 4
container_start_page 377
container_title Journal of emergency nursing
container_volume 37
creator Paparella, Susan
description In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.
doi_str_mv 10.1016/j.jen.2011.03.010
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_876191526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0099176711001243</els_id><sourcerecordid>876191526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</originalsourceid><addsrcrecordid>eNp9kcFO3DAQQK0KVBbaD-CCIjjQS1KPE9sxHKpqKQWJCgm1B06W7UxK0l1nsRMk_h6vFjgglZMvb5488wjZB1oABfG1L3r0BaMABS0LCvQDmQFnMmdKiC0yo1SpHKSQO2Q3xp5SyiWoj2SHgWC0EjAj5aUfg3lAP0wxu7g9u7leDmF1N3g8yebGZ7fDlP0y3vzFbLzD7KaL_759ItutWUT8_PzukT_nP37PL_Kr65-X8-9XuasEH3OF1LatVcyU3DXc0ZZXjUFbM2UZVsB4LRTyBqWylXVC2NLZxipAxSSrZLlHjjfeVRjuJ4yjXnbR4WJhPKbv6loKUGlfkcgv75JQs5IDMFhLD9-g_TAFn_bQdc3S4QDKBB39DwIOVc0lF2sVbCgXhhgDtnoVuqUJjxqoXgfSvU6B9DqQpqVOgdLMwbN5sktsXideiiTgdANguuxDh0FH16F32HQB3aiboXtH_wQJ-Zzk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1514857567</pqid></control><display><type>article</type><title>Intravenous HYDROmorphone: Can You Manage the Risk?</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>ScienceDirect Journals</source><creator>Paparella, Susan</creator><creatorcontrib>Paparella, Susan</creatorcontrib><description>In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.</description><identifier>ISSN: 0099-1767</identifier><identifier>EISSN: 1527-2966</identifier><identifier>DOI: 10.1016/j.jen.2011.03.010</identifier><identifier>PMID: 21620461</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Acute Pain - drug therapy ; Adult ; Analgesics ; Analgesics, Opioid - poisoning ; Analgesics, Opioid - therapeutic use ; Anesthesia ; Drug dosages ; Drug Overdose ; Emergency Nursing - methods ; Fatal Outcome ; Health facilities ; Heart Arrest - chemically induced ; Hospitals ; Humans ; Hydromorphone ; Hydromorphone - poisoning ; Hydromorphone - therapeutic use ; Injections, Intravenous ; Male ; Medication Errors - prevention &amp; control ; Nursing ; Pain management ; Patients ; Respiratory Insufficiency - chemically induced ; Risk management</subject><ispartof>Journal of emergency nursing, 2011-07, Vol.37 (4), p.377-380</ispartof><rights>2011 Emergency Nurses Association</rights><rights>Copyright Elsevier Limited Jul 2011</rights><rights>Copyright Elsevier Science Ltd. Jul 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</citedby><cites>FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,12846,27924,27925,30999,31000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21620461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paparella, Susan</creatorcontrib><title>Intravenous HYDROmorphone: Can You Manage the Risk?</title><title>Journal of emergency nursing</title><addtitle>J Emerg Nurs</addtitle><description>In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.</description><subject>Acute Pain - drug therapy</subject><subject>Adult</subject><subject>Analgesics</subject><subject>Analgesics, Opioid - poisoning</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Anesthesia</subject><subject>Drug dosages</subject><subject>Drug Overdose</subject><subject>Emergency Nursing - methods</subject><subject>Fatal Outcome</subject><subject>Health facilities</subject><subject>Heart Arrest - chemically induced</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hydromorphone</subject><subject>Hydromorphone - poisoning</subject><subject>Hydromorphone - therapeutic use</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medication Errors - prevention &amp; control</subject><subject>Nursing</subject><subject>Pain management</subject><subject>Patients</subject><subject>Respiratory Insufficiency - chemically induced</subject><subject>Risk management</subject><issn>0099-1767</issn><issn>1527-2966</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2S</sourceid><recordid>eNp9kcFO3DAQQK0KVBbaD-CCIjjQS1KPE9sxHKpqKQWJCgm1B06W7UxK0l1nsRMk_h6vFjgglZMvb5488wjZB1oABfG1L3r0BaMABS0LCvQDmQFnMmdKiC0yo1SpHKSQO2Q3xp5SyiWoj2SHgWC0EjAj5aUfg3lAP0wxu7g9u7leDmF1N3g8yebGZ7fDlP0y3vzFbLzD7KaL_759ItutWUT8_PzukT_nP37PL_Kr65-X8-9XuasEH3OF1LatVcyU3DXc0ZZXjUFbM2UZVsB4LRTyBqWylXVC2NLZxipAxSSrZLlHjjfeVRjuJ4yjXnbR4WJhPKbv6loKUGlfkcgv75JQs5IDMFhLD9-g_TAFn_bQdc3S4QDKBB39DwIOVc0lF2sVbCgXhhgDtnoVuqUJjxqoXgfSvU6B9DqQpqVOgdLMwbN5sktsXideiiTgdANguuxDh0FH16F32HQB3aiboXtH_wQJ-Zzk</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Paparella, Susan</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Intravenous HYDROmorphone: Can You Manage the Risk?</title><author>Paparella, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Pain - drug therapy</topic><topic>Adult</topic><topic>Analgesics</topic><topic>Analgesics, Opioid - poisoning</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Anesthesia</topic><topic>Drug dosages</topic><topic>Drug Overdose</topic><topic>Emergency Nursing - methods</topic><topic>Fatal Outcome</topic><topic>Health facilities</topic><topic>Heart Arrest - chemically induced</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hydromorphone</topic><topic>Hydromorphone - poisoning</topic><topic>Hydromorphone - therapeutic use</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medication Errors - prevention &amp; control</topic><topic>Nursing</topic><topic>Pain management</topic><topic>Patients</topic><topic>Respiratory Insufficiency - chemically induced</topic><topic>Risk management</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paparella, Susan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Proquest Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of emergency nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paparella, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous HYDROmorphone: Can You Manage the Risk?</atitle><jtitle>Journal of emergency nursing</jtitle><addtitle>J Emerg Nurs</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>37</volume><issue>4</issue><spage>377</spage><epage>380</epage><pages>377-380</pages><issn>0099-1767</issn><eissn>1527-2966</eissn><abstract>In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>21620461</pmid><doi>10.1016/j.jen.2011.03.010</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0099-1767
ispartof Journal of emergency nursing, 2011-07, Vol.37 (4), p.377-380
issn 0099-1767
1527-2966
language eng
recordid cdi_proquest_miscellaneous_876191526
source Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Journals
subjects Acute Pain - drug therapy
Adult
Analgesics
Analgesics, Opioid - poisoning
Analgesics, Opioid - therapeutic use
Anesthesia
Drug dosages
Drug Overdose
Emergency Nursing - methods
Fatal Outcome
Health facilities
Heart Arrest - chemically induced
Hospitals
Humans
Hydromorphone
Hydromorphone - poisoning
Hydromorphone - therapeutic use
Injections, Intravenous
Male
Medication Errors - prevention & control
Nursing
Pain management
Patients
Respiratory Insufficiency - chemically induced
Risk management
title Intravenous HYDROmorphone: Can You Manage the Risk?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A57%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20HYDROmorphone:%20Can%20You%20Manage%20the%20Risk?&rft.jtitle=Journal%20of%20emergency%20nursing&rft.au=Paparella,%20Susan&rft.date=2011-07-01&rft.volume=37&rft.issue=4&rft.spage=377&rft.epage=380&rft.pages=377-380&rft.issn=0099-1767&rft.eissn=1527-2966&rft_id=info:doi/10.1016/j.jen.2011.03.010&rft_dat=%3Cproquest_cross%3E876191526%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1514857567&rft_id=info:pmid/21620461&rfr_iscdi=true